1 |
Yu MY, Jia HJ, Zhang J, Ran GH, Liu Y, Yang XH. Exosomal miRNAs-mediated macrophage polarization and its potential clinical application. Int Immunopharmacol 2023;117:109905. [PMID: 36848789 DOI: 10.1016/j.intimp.2023.109905] [Reference Citation Analysis]
|
2 |
Dong Z, Dai B, Fang K, Duan K, Sui C, Geng L, Yang J. Expression characteristics, immune signature, and prognostic value of the SOCS family identified by multiomics integrative analysis in liver cancer.. [DOI: 10.21203/rs.3.rs-2411830/v1] [Reference Citation Analysis]
|
3 |
Cabrera-Galván JJ, Araujo E, de Mirecki-Garrido M, Pérez-Rodríguez D, Guerra B, Aranda-Tavío H, Guerra-Rodríguez M, Brito-Casillas Y, Melián C, Martínez-Martín MS, Fernández-Pérez L, Recio C. SOCS2 protects against chemical-induced hepatocellular carcinoma progression by modulating inflammation and cell proliferation in the liver. Biomed Pharmacother 2023;157:114060. [PMID: 36455458 DOI: 10.1016/j.biopha.2022.114060] [Reference Citation Analysis]
|
4 |
Chi B, Zheng Y, Xie F, Fu W, Wang X, Gu J, Yang J, Yin J, Cai L, Tang P, Li J, Guo S, Wang H. Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway. Cancer Cell Int 2022;22:415. [PMID: 36539807 DOI: 10.1186/s12935-022-02835-0] [Reference Citation Analysis]
|
5 |
da Cruz NS, Pasquarelli-do-nascimento G, e Oliveira ACP, Magalhães KG. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression. Biomedicines 2022;10:2344. [DOI: 10.3390/biomedicines10102344] [Reference Citation Analysis]
|
6 |
Tulessin M, Sarker RSJ, Griger J, Leibing T, Geraud C, Weichert W, Steiger K, Mogler C. Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis. Cells 2022;11:2129. [DOI: 10.3390/cells11142129] [Reference Citation Analysis]
|